lobbying_activities: 2067533
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2067533 | 7552ca6f-db5c-42f5-ab73-39b220d1a626 | Q4 | AKIN GUMP STRAUSS HAUER & FELD | 682 | OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC. | 2017 | fourth_quarter | CPT | The Innovation Act (H.R. 9); Helping Families in Mental Health Crisis Act (H.R. 2646); Mental Health Reform Act of 2015 (H.R. 1945); Mental Health Awareness and Improvement Act (S. 1893). | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2018-01-18T12:16:24.327000-05:00 |